Bromide

Bromide

SCHEMBL186496

CCCCOC(=O)C(C)OC(=O)C[n+]1ccn(C)c1.[Br-]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HSP90AA1 P07900 1/20 0.40
ALDH1A1 P00352 2/20 0.33
NPSR1 Q6W5P4 1/20 0.32
L3MBTL1 Q9Y468 3/20 0.32
TSHR P16473 2/20 0.32
ALOX15 P16050 1/20 0.32
ATM Q13315 1/20 0.30
ESR1 P03372 1/20 0.30
NPC1 O15118 1/20 0.30
HPGD P15428 1/20 0.30
RAB9A P51151 1/20 0.30
LMNA P02545 1/20 0.30
POLB P06746 1/20 0.30
FDPS P14324 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15897197 0.99 SMN1; SMN2 (0.39) SMN1; SMN2MEN1KMT2AHSP90AA1ALDH1A1
SCHEMBL15896753 0.99 SMN1; SMN2 (0.39) SMN1; SMN2MEN1KMT2AHSP90AA1ALDH1A1
SCHEMBL10279372 0.95 MEN1 (0.40) SMN1; SMN2MEN1KMT2AHSP90AA1ALDH1A1
SCHEMBL15896806 0.95 MEN1 (0.40) SMN1; SMN2MEN1KMT2AHSP90AA1ALDH1A1
Bromide SCHEMBL186465 0.92 MEN1 (0.36) SMN1; SMN2MEN1KMT2AHSP90AA1
SCHEMBL15896788 0.91 MEN1 (0.35) SMN1; SMN2MEN1KMT2AHSP90AA1
SCHEMBL15896805 0.91 MEN1 (0.35) SMN1; SMN2MEN1KMT2AHSP90AA1
Bromide SCHEMBL186494 0.88 MEN1 (0.35) SMN1; SMN2MEN1KMT2AHSP90AA1ALDH1A1
SCHEMBL15896738 0.87 MEN1 (0.33) SMN1; SMN2MEN1KMT2AHSP90AA1
SCHEMBL15896752 0.87 MEN1 (0.33) SMN1; SMN2MEN1KMT2AHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120071661-A1 Ionic Liquid Solvents DUBLIN CITY UNIVERSITY (IE) 2012-03-22 US claimed
EP-2401258-A1 IONIC LIQUID SOLVENTS Dublin City University (IE) 2012-01-04 EP claimed
WO-2010097412-A1 IONIC LIQUID SOLVENTS DUBLIN CITY UNIVERSITY (IE) 2010-09-02 WO claimed
US-8785655-B2 Ionic liquid solvents DUBLIN CITY UNIVERSITY (IE) 2014-07-22 US disclosed
US-20120071661-A1 Ionic Liquid Solvents DUBLIN CITY UNIVERSITY (IE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071661-A1 Ionic Liquid Solvents EBP, PAICS, HACD3 SMN1; SMN2 2787/4885MEN1 3011/4885KMT2A 3968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.